Edesa Biotech shareholders approve 1.725M share increase to 2019 equity plan

Edesa Biotech, Inc.

Shareholders approved amendment to 2019 Equity Incentive Compensation Plan increasing share reserve by 1,725,000 shares.
Fungible share pool provisions removed; incentive stock option limit raised from 171,429 to 300,000 shares.
All seven director nominees elected: Chypyha, Liu, MacDonald, Marshall, Nijhawan, Olson, Sistilli.
Advisory vote on executive compensation approved with 2,215,325 for, 178,016 against.
MNP LLP appointed as independent auditor for fiscal year ending September 30, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.